The University of Minnesota Youth and AIDS Projects' Adolescent Early Intervention Program: A model to link HIV-seropositive youth with care

Journal of Adolescent Health

Volumn 23, Issue 2 SUPPL., 1998, Pages 115-121

  Remafedi, Gary ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Box 721 UMHC ^*  (United States)

Author keywords

Acquired immunodeficiency syndrome; Adolescence; Health care services; Human immunodeficiency virus; Special Projects of National Significance Program; Youth

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; DISEASE CONTROL; FEMALE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; POVERTY; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SOCIOECONOMICS; SUBSTANCE ABUSE; SUICIDE; UNEMPLOYMENT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADOLESCENT HEALTH SERVICES; ADULT; CASE MANAGEMENT; FEMALE; HEALTH EDUCATION; HIV INFECTIONS; HUMANS; INTERVENTION STUDIES; MALE; MINNESOTA; MODELS, ORGANIZATIONAL; NATIONAL HEALTH PROGRAMS; PROGRAM EVALUATION; RISK FACTORS;

EID: 0031827740     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-139X(98)00059-7     Document Type: Article

References (7)

1. HIV/AIDS Six-Month Surveillance Report. Minneapolis, MN: Minnesota Department of Health. January 1997.
2. HIV/AIDS Surveillance Report. Atlanta, GA: Centers for Disease Control and Prevention; 1996;8:5.
3. Unpublished HIV/AIDS surveillance data, Minnesota Department of Health, 1997.
4. Remafedi G., Lauer T. Survival trends in adolescents with HIV infection. Arch Pediatr Adolesc Med. 149:1995;1093-1096.
5. Remafedi G., Lauer T. The health and psychosocial status of HIV-seropositive youth. J Adolesc Health. 18:1996;263-269.
6. Remafedi G., Higgins M. The use of public health disease strategies to link HIV-seropositive adolescents with care. J Adolesc Health. 20:1997;164.
7. Karnofsky D.A., Abelmann W.H., Craver L.F., Burchenal J.H. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer. 1:1948;634-656.